What are the typical clinical features and presentation of primary polycythemia (polycythemia vera)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Presentation of Primary Polycythemia (Polycythemia Vera)

Primary polycythemia (polycythemia vera) typically presents with elevated hemoglobin/hematocrit (>16.5 g/dL in men, >16.0 g/dL in women), often accompanied by thrombocytosis (53% of patients) and leukocytosis (49%), along with characteristic symptoms including aquagenic pruritus (48%), splenomegaly (36%), erythromelalgia (3-5.3%), headache, and visual disturbances. 1, 2

Hematologic Features

The cardinal laboratory finding is erythrocytosis, which is a required diagnostic criterion 3, 2:

  • Hemoglobin >16.5 g/dL (hematocrit >49%) in men
  • Hemoglobin >16.0 g/dL (hematocrit >48%) in women

Additional blood count abnormalities commonly include:

  • Thrombocytosis (present in 53% of patients) 2
  • Leukocytosis (present in 49% of patients) 2
  • Microcytosis from iron deficiency (due to phlebotomy or occult bleeding) 1

Clinical Symptoms and Signs

Microvascular Disturbances

These result from platelet-endothelial interactions causing transient occlusive phenomena 1:

  • Headache and light-headedness
  • Transient neurologic or ocular disturbances (14% have visual changes) 2
  • Tinnitus
  • Atypical chest discomfort
  • Paresthesias
  • Erythromelalgia (3-5.3%): painful burning sensation of feet/hands with erythema and warmth, responds dramatically to low-dose aspirin within hours 1, 2

Pruritus

Generalized pruritus exacerbated by hot baths is a characteristic feature, documented in 48% of patients either at diagnosis or later 1. This can be the most debilitating symptom, causing sleep deprivation and interference with daily activities 1.

Physical Examination Findings

  • Splenomegaly (36% of patients) with associated abdominal discomfort 2
  • Plethora (ruddy complexion, engorged veins) 1

Thrombotic and Hemorrhagic Complications

Thromboembolism is the most important complication 4:

  • Arterial thrombosis occurs in 16% prior to or at diagnosis 2
  • Venous thrombosis in 7%, often in unusual sites like splanchnic veins (Budd-Chiari syndrome) 1, 2
  • Increased bleeding risk, especially with extreme thrombocytosis (platelet count ≥1000 × 10⁹/L) due to acquired von Willebrand disease 2

Molecular and Laboratory Markers

More than 95% of patients harbor JAK2 mutations 3, 4, 2:

  • JAK2V617F mutation in exon 14 (>90% of cases) 3
  • JAK2 exon 12 mutations (2-3% of cases) 3

Serum erythropoietin levels are characteristically low or low-normal (specificity >90%, but sensitivity <70%) 1. A high serum EPO level essentially excludes PV and suggests secondary polycythemia 1.

Bone Marrow Findings

Characteristic morphologic changes include 1:

  • Hypercellularity (panmyelosis)
  • Increased megakaryocytes with cluster formation
  • Giant megakaryocytes with pleomorphism
  • Mild reticulin fibrosis (12% at diagnosis)
  • Decreased bone marrow iron stores

Constitutional Symptoms

Patients may experience 5:

  • Fatigue
  • Night sweats
  • Weight loss
  • Fever

These constitutional symptoms are more prominent when disease progresses toward myelofibrosis 5.

Important Clinical Pitfalls

A common diagnostic error is missing PV in patients with upper-normal hematocrit who have other PV-related features (thrombocytosis, leukocytosis, microcytosis, splenomegaly, aquagenic pruritus, unusual thrombosis, erythromelalgia) 1. In such cases, the diagnosis should be actively pursued with serum EPO levels and bone marrow examination, regardless of the hematocrit value 1.

Iron deficiency from chronic phlebotomy or occult bleeding can mask the true degree of erythrocytosis, presenting with microcytosis and a deceptively lower hematocrit 1.

Age and Epidemiology

PV is most prevalent in the seventh decade of life, with a male-to-female ratio of 1.5:1 5. However, the disease can occur at any age, and younger patients (≤40 years) have significantly better survival exceeding 35 years 6.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.